- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Gender equality is a human right and critical to the performance and effectiveness of UNAIDS. The importance of advancing gender equality, including through reaching gender parity, is increasingly being recognized.
The UNAIDS Gender Action Plan 2018–2023 was launched on 8 June 2018 and sets out four targets and 30 concrete actions to drive progress against the targets.
Keywords: gender equality, women empowerment, diversity, inclusion
In 2018, UNFPA set in motion a strategic effort, based on quality data, to achieve three zeros by 2030: zero unmet need for contraception; zero preventable maternal deaths; and zero gender-based violence and harmful practices.
Given the impact of gender inequality on the sexual and reproductive health of women and girls and the health of women and their children, UN Women developed this programming guide that provides practical guidance and tools to understand the influence of gender inequality on sexual, reproductive, maternal, newborn, child and adolescent health (SRMNCAH), and how to effectively integrate gender equality into programming.
The guide serves as an important resource to complement and build on existing guidance and tools to strengthen gender equality efforts to improve health outcomes for women, children, and adolescents.
Keywords: human rights, sexual and reproductive health, health care, child and adolescent health
This document has been designed to provide a framework to support local and national STI prevalence studies. The aim of these studies is to understand the burden of disease of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), two priority STIs that can cause adverse birth outcomes. For this, the objective is to epidemiologically describe the prevalence of these two infections among pregnant women and, by proxy, the general population in the country.
Women are estimated to account for one third of the 275 million people who use drugs globally. Women who use drugs are consistently reported to have less access to harm reduction services and to be at higher risk of HIV and hepatitis C infection than men who use drugs. Despite these reports, robust data on this subject is scarce, and research on drug use and related health issues rarely produces information about women.
The Global State of Harm Reduction 2018 identifies a number of key issues and themes reflected across the world that limit women’s access to harm reduction services, and highlights cases of good practice.
STI prevention and control has widespread public health benefits. Left untreated, some STIs increase the risk of HIV transmission during unprotected sexual contact and lead to complications, such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, miscarriage, fetal death and congenital infections. Estimated STI-related mortality includes 200 000 fetal and neonatal deaths each year due to syphilis in pregnancy and over 280 000 cervical cancer deaths each year due to HPV.
When medically justified, a caesarean section can effectively prevent maternal and perinatal mortality and morbidity. However, there is no evidence to show that C-section delivery has any benefits for women or infants who do not require the procedure.
There has been a marked shift in the global development agenda to develop, fund and implement multisectoral interventions that jointly advance both sexual and reproductive health and rights (SRHR), and HIV prevention, treatment and care. These joint interventions are increasingly being implemented by countries, especially within primary health care settings.
1 in 3 women will experience physical and/or sexual violence in their lifetime, mostly by an intimate partner. This violence has a profound impact on the health of women and their families. WHO brings attention to this important public health issue through research and evidence building, development of guidelines and tools for the health sector, strengthening country capacity, and advocacy to increase political will. Here are some of WHO’s key achievements and priorities in the coming years to address violence against women.
This document provides an overview of sexual and reproductive health and rights issues that may be important for the human rights, health and well-being of adolescents (aged 10–19 years) and the relevant World Health Organization (WHO) guidelines on how to address them in an easily accessible, user-friendly format. The document serves as a gateway to the rich body of WHO guidelines, and as a handy resource to inform advocacy, policy and programme/project design and research. It aims to support the implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health 2016–2030 (1), and is aligned with the WHO Global Accelerated Action for the Health of Adolescents (AA-HA!) as well as the WHO Operational Framework on Sexual Health and Its Linkages to Reproductive Health (2,3).